Bunkerhill Health vs Elucid
A physician sends coronary CT angiography images to Elucid, trained analysts segment a 3D model of the arteries, and the software quantifies plaque, including non-calcified plaque and lipid-rich necrotic core. PlaqueIQ has two 510(k)s, the second decided in September 2026. The cleared claim supports clinicians and does not diagnose disease. Elucid bills per analysis with no public rate, and turnaround time is unpublished. A cardiology imaging center with CCTA volume is the customer, helped by CPT 75577, for which Medicare pays about $1,012 at imaging centers. That sum goes to the performing site and is separate from Elucid's fee.
Bunkerhill sells to health systems. Its listed coronary 510(k)s are calcium algorithms, gated and contrast CAC, so a cardiology program that needs plaque composition measured looks to Elucid for it. Its homepage also lists osteoporosis detection from prior CTs, and K243779 covers abdominal aortic quantification. A SOC 2 Type II report is available on request.
Radiology · Reviewed November 1, 2026

Bunkerhill Health
by Bunkerhill Health
AI agent platform for health systems covering referrals, prior auth, care coordination and imaging, built on nine FDA-cleared imaging algorithms.

Elucid
by Elucid Bioimaging
PlaqueIQ analyzes coronary plaque on CT angiograms, with FDA 510(k) clearances in September 2024 and September 2026.
When to pick each one
Bunkerhill Health
- Gated CAC, K240369 (September 2024)
- Abdominal aortic quantification, K243779 (July 2025)
- SOC 2 Type II report available on request
Elucid
- PlaqueIQ 510(k) K241524 (September 2024), second K261855 (September 2026)
- Medicare pays about $1,012 for CPT 75577 at imaging centers
- Quantifies non-calcified plaque and lipid-rich necrotic core
Score
Each row shows points earned of points available under the published rubric.
Bunkerhill Health
40of 100
Elucid
43of 100
| Dimension | Bunkerhill Health | Elucid | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 10 / 10 | 0 / 10 | +10 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 0 / 18.2 | 12.7 / 18.2 | -12.7 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Bunkerhill Health
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Quote only | n/a | n/a | No public price. The site offers a demo request only. |
Elucid
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Per analysis | n/a | n/a | No public price. Providers are billed per analysis. Category I CPT code 75577 has applied since January 1, 2026. |
Evidence
Bunkerhill Health
FDA decisions
K260167 (opens in new tab)510(k)2026-03-06
Bunkerhill Contrast AVC
K260166 (opens in new tab)510(k)2026-03-06
Bunkerhill Contrast CAC
K250662 (opens in new tab)510(k)2025-10-03
Bunkerhill MAC
K250649 (opens in new tab)510(k)2025-09-19
Bunkerhill ECG-EF
K243779 (opens in new tab)510(k)2025-07-01
Bunkerhill Abdominal Aortic Quantification (AAQ)
Show 4 more
K242295 (opens in new tab)510(k)2025-04-08
BunkerHill BMD
K243229 (opens in new tab)510(k)2025-01-27
Bunkerhill AVC
K240369 (opens in new tab)510(k)2024-09-27
CAC (gated) Algorithm
K230223 (opens in new tab)510(k)2023-04-25
iCAC Device
Elucid
FDA decisions
K261855 (opens in new tab)510(k)2026-09-18
Elucid PlaqueIQ
K241524 (opens in new tab)510(k)2024-09-12
Elucid PlaqueIQ
Peer-reviewed
2 PubMed records name Elucid.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Bunkerhill Health | Elucid |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | n/a | n/a |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.
